Kellie Machlus: CCL5 as a Driver of Megakaryopoiesis and Platelet Recovery
Kellie Machlus, Associate Professor at Harvard Medical School, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“So excited to share with everyone our latest publication – led by Maria Barrachina while she was in the lab (go work with her in Ohio!).
This is an extension of our previous work, which now shows in vivo and BM organoid effects of CCL5 on the MK lineage including HSC and MKP expansion and increased platelet production after thrombocytopenia.
Check it out!!”
Title: CCL5 derived from platelets increases megakaryocyte proplatelet formation
Authors: Kellie R. Machlus, Kelly E. Johnson, Rajesh Kulenthirarajan, Jodi A. Forward, Mason D. Tippy, Thomas S. Soussou, Saleh H. El-Husayni, Stephen K. Wu, Suming Wang, Randolph S. Watnick, Joseph E. Italiano Jr., Elisabeth M. Battinelli
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?
-
Aug 16, 2026, 06:05Nicolas Hubacz: A New Target for Stroke Recovery